Progenity Revenue and Competitors

Claim your profile

Location

$248.5M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Progenity's estimated annual revenue is currently $45M per year.(i)
  • Progenity received $125.0M in venture funding in November 2017.
  • Progenity's estimated revenue per employee is $293,791
  • Progenity's total funding is $248.5M.

Employee Data

  • Progenity has 153 Employees.(i)
  • Progenity grew their employee count by -70% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$564.8M374927%$404.1M$6.4B
#2
$1.7M11450%N/AN/A

Progenity helps patients and their families Prepare for Life, with medically relevant health information starting before conception, through pregnancy, childhood, and adulthood. Using our highly-complex molecular diagnostic testing, healthcare providers can access the most advanced genomic technology to guide patient care at critical life stages.

keywords:Biotechnology,Healthcare,Medical Diagnostics

$248.5M

Total Funding

153

Number of Employees

$45M

Revenue (est)

-70%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Progenity News

2022-04-17 - Progenity Appoints Paul Shabram to Lead Technical Operations of the Company’s Ingestible Drug/Device Platforms

Progenity Appoints Paul Shabram to Lead Technical Operations of the Company's Ingestible Drug/Device Platforms. Progenity, Inc. Mon, April 25,...

2022-04-17 - Progenity, Inc. (NASDAQ:PROG) Given Consensus ...

Progenity, Inc, a biotechnology company, provides develops and commercializes molecular testing products in the United States. The company...

2022-03-30 - Progenity Announces Two Poster Presentations at Controlled ...

Progenity, Inc. is a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics and is developing a...

2021-11-23 - Progenity Gets $44 Million in Warrant Exercises Since August

By Chris Wack Progenity Inc. said it has received more than $44 million in warrant exercises since August. The biotechnology company said that as a result of previously issued warrants being exercised and other capital-raising transactions, it believes its current liquidity position provides s ...

2021-10-12 - Progenity : announces it has successfully been assigned a patent for the treatment of a disease of the gastrointestinal tract

Patent number: 11134889 Abstract: This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a SMAD7 inhibitor. Type: Grant Filed: December 14, 2017 Date of Patent: October 5, 2021 Assignee: Progenity, Inc. Inventors: Mitchell Lawrence Jones ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$40.3M153-6%$36M
#2
$41.2M153-2%N/A
#3
$24.4M15361%N/A
#4
N/A15322%N/A
#5
$56.3M155216%N/A

Progenity Funding

DateAmountRoundLead InvestorsReference
2016-08-19$12.0MUndisclosedArticle
2017-11-08$125.0MBAthyrium Capital ManagementArticle